THIRD AMENDMENT TO MASTER SERVICES AGREEMENTMaster Services Agreement • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
Contract Type FiledJune 23rd, 2020 Company IndustryTHIS THIRD AMENDMENT TO MASTER SERVICES AGREEMENT (“3rd Amendment”) dated as of June 20, 2016 (“Effective Date”) is entered into by and between Accredo Health Group, Inc. (“Service Provider”) and Aegerion Pharmaceuticals, Inc., a Delaware corporation with offices at One Main Street Suite 800, Cambridge, MA 02142 (“Aegerion”) as successor in interest to AstraZeneca Pharmaceutical LP, a Delaware limited partnership with offices at 1800 Concord Pike, Wilmington, Delaware 19803 (“AstraZeneca”).
THIRD AMENDMENT TO MASTER SERVICES AGREEMENTMaster Services Agreement • May 11th, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
Contract Type FiledMay 11th, 2020 Company IndustryTHIS THIRD AMENDMENT TO MASTER SERVICES AGREEMENT (“3rd Amendment”) dated as of June 20, 2016 (“Effective Date”) is entered into by and between Accredo Health Group, Inc. (“Service Provider”) and Aegerion Pharmaceuticals, Inc., a Delaware corporation with offices at One Main Street Suite 800, Cambridge, MA 02142 (“Aegerion”) as successor in interest to AstraZeneca Pharmaceutical LP, a Delaware limited partnership with offices at 1800 Concord Pike, Wilmington, Delaware 19803 (“AstraZeneca”).